Hippocratic AI's mission is to develop the safest artificial Health General Intelligence (HGI). The company believes that safe HGI can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
05/16/23 | $50,000,000 | Seed |
Andreessen Horowitz General Catalyst Partners | undisclosed |
01/09/25 | $141,000,000 | Series B |
A16z General Catalyst Partners Kleiner Perkins Caufield and Byers NVIDIA Premji Invest SV Angel Universal Health Services WellSpan Health | $1,640,000,000 |